0001365618-12-000002.txt : 20120705 0001365618-12-000002.hdr.sgml : 20120704 20120705183916 ACCESSION NUMBER: 0001365618-12-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120702 FILED AS OF DATE: 20120705 DATE AS OF CHANGE: 20120705 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hove Anders D CENTRAL INDEX KEY: 0001365618 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34973 FILM NUMBER: 12949173 MAIL ADDRESS: STREET 1: 30 ROCKEFELLER PLAZA, SUITE 5508 CITY: NEW YORK STATE: NY ZIP: 10112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anacor Pharmaceuticals Inc CENTRAL INDEX KEY: 0001411158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 251854385 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1020 E. MEADOW CIRCLE CITY: PALO ALTO STATE: CA ZIP: 94303 BUSINESS PHONE: 650-543-7500 MAIL ADDRESS: STREET 1: 1020 E. MEADOW CIRCLE CITY: PALO ALTO STATE: CA ZIP: 94303 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2012-07-02 0001411158 Anacor Pharmaceuticals Inc ANAC 0001365618 Hove Anders D C/O VENROCK 3340 HILLVIEW AVE. PALO ALTO CA 94304 1 0 1 0 Common Stock 2012-07-02 4 J 0 900000 0 D 3725535 I By Funds and LLC's Common Stock 2012-07-02 4 J 0 79450 0 A 3804985 I By Funds and LLC's On July 2, 2012, Venrock Associates IV, L.P. ("VA4"), Venrock Partners, L.P. ("VP"), Venrock Entrepreneurs Fund IV, L.P. ("VEF4"), Venrock Healthcare Capital Partners, L.P. ("VHCP") and VHCP Co-Investment Holdings, LLC ("VHCP Co-Invest") (collectively, the "Venrock Funds") distributed an aggregate of 900,000 shares of the common stock of the Issuer to their respective partners pro rata based on their respective interests in the Venrock Funds (the "Distribution"). Following the Distribution, the Venrock Funds' shares are held as follows: 1,721,350 shares held by VA4, 351,036 shares held by VP, 42,293 shares held by VEF4, 1,361,755 shares held by VHCP and 249,101 shares held by VHCP Co-Invest. Venrock Management IV, LLC ("VM4"), Venrock Partners Management, LLC ("VPM") and VEF Management IV, LLC ("VEFM4") are the sole general partners of VA4, VP and VEF4, respectively, and may be deemed to beneficially own these shares. VHCP Management, LLC ("VHCP Management") is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. Anders Hove is a member of VM4, VPM and VEFM4 and a managing member of VHCP Management. Dr. Hove expressly disclaims beneficial ownership over all shares held by VA4, VP, VEF4, VHCP, VHCP Co-Invest, VM4, VPM, VEFM4 and VHCP Management except to the extent of his indirect pecuniary interest therein. In the Distribution, VM4 received 5,663 shares, VPM received 1,193 shares, VEFM4 received 82 shares, VHCP Management received 12,335 shares, Venrock Associates V, L.P. ("VA5") received 55,474 shares and Venrock Partners V, L.P. ("VP5") received 4,703 shares. Venrock Management V, LLC ("VM5") and Venrock Partners Management V, LLC ("VPM5") are the sole general partners of VA5 and VP5, respectively, and may be deemed to beneficially own these shares. Dr. Hove is a member of VM5 and VPM5. Dr. Hove expressly disclaims beneficial ownership over all shares held by VA5, VP5, VM5 and VPM5 except to the extent of his indirect pecuniary interest therein. For VM4, VPM, VEFM4 and VHCP Management, this represents a change in form of ownership from indirect to direct but does not represent a change in beneficial ownership. /s/ Anders D. Hove 2012-07-05